ARIAD Pharma (ARIA) Shares Continue Lower as Feuerstein Piece Highlighted
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/26/2024
- Wall Street stocks fall as weak GDP growth spreads rate-cut gloom
- Q1 US GDP shows surprise slowing and uncomfortable inflation
- Alphabet (GOOGL) soars 16% on Q1 results beat, first-ever dividend
- Meta shares dip on softer Q2 revenue guidance, elevated AI spending plans
- Oil settles higher as weak U.S. economic growth offset by supply concerns
- Rubrik (RBRK) Prices Upsized 23.5M Share IPO at $32/sh
- Union Pacific beats profit estimates on stronger pricing, resumes share buyback
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Hertz Global (HTZ) misses earnings expectations as fleet costs weigh
- Teladoc (TDOC) Misses Q1 EPS by 3c, offers outlook
- After-hours movers: Alphabet, Microsoft, Snap, Intel, and more
- Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
ARIAD Pharma (ARIA) puts active after former presidential candidate Senator Bernie Sanders posted to Twitter
October 14, 2016 1:53 PM EDTARIAD Pharma (NASDAQ: ARIA) October weekly 12.5 and 13 puts are active on total put volume of 2,500 contracts (900 calls) on former presidential candidate Senator Bernie Sanders posted to Twitter: "Drug corporations' greed is unbelievable. Ariad has raised the price of a leukemia drug to almost $199,000 a... More
ARIAD Pharma (ARIA) Criticized in Tweet by Bernie Sanders
October 14, 2016 1:43 PM EDT(Updated - October 14, 2016 1:50 PM EDT)
Shares of ARIAD Pharma (NASDAQ: ARIA) plunged Friday following a tweet by Senator and former presidential hopeful Bernie Sanders. Sanders tweeted a STAT article from Oct. 7th discussing an increase in the price of ARIAD's leukemia drug,... More
